Why is Remus Pharma. falling/rising?

As of 18-Sep, Remus Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 795.95, which reflects a decrease of Rs 15.3 or 1.89%. The stock has underperformed significantly, with a 1-week return of -5.41% and a 1-month return of -13.13%. Additionally, it is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The stock is also close to its 52-week low, being only 2.63% away from Rs 775. Despite a rise in investor participation, with delivery volume increasing by 17.02% against the 5-day average, the overall performance remains weak, and no positive factors are noted to counterbalance the negative trends.
In the broader market context, the Sensex has shown a positive return of +1.67% over the past week, contrasting sharply with Remus Pharmaceuticals' negative performance. This divergence highlights the stock's struggles relative to the benchmark index, which has also posted gains of +2.20% over the past month and +7.52% year-to-date. The significant underperformance of Remus Pharmaceuticals compared to the Sensex suggests that investor sentiment towards the stock is weak, further exacerbated by its declining price trends and lack of positive catalysts in the market.